Tag: EXCELLENT

cerenovus svin 2022

Cerenovus reveals positive stent-retriever thrombectomy outcomes within EXCELLENT registry

Cerenovus, part of Johnson & Johnson MedTech, has today announced positive primary outcomes from the real-world EXCELLENT registry, focused on stroke-inducing blood clot removal...

ISC 2022: Global EXCELLENT study “shows how much stroke thrombectomy has...

Mechanical removal of blood clots reduced post-stroke disability in nearly half of “all-comer” real-world stroke patients in a global study, according to preliminary late-breaking...